Bangalore, India · Founded 2017 · Privately Held (backing)
Developer of novel drugs designed to be used in vaccines for respiratory viruses. Mynvax is based in Bangalore, India and was founded in 2017. Its last known valuation is $29.8 million. It has raised $12.7 million.
Last price · $/share
—
Implied valuation
$29.8M
Total raised
$12.7M
Last round
—
Cap table — not yet on record
Mynvax's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mynvax with a free account
·The complete investor list: 15 names
·Watch Mynvax: the Monday email on marks, rounds and moves
